Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer.
- Citation:
- Eur J Cancer vol 201 113914
- Year:
- 2024
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- Alliance-data-source,-external-user
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 3734
- Children:
- None
- Pharmas:
- Bristol-Myers Squibb, Genentech, and Pfizer
- Grants:
- U10CA180821, U10CA180882, UG1CA233163, UG1CA233373, P30CA 014089, U10CA180888, UG1CA180830(SWOG)
- Corr. Author:
- Authors:
- Hiroyuki Arai Yan Yang Yasmine Baca Joshua Millstein Tadamichi Denda Fang-Shu Ou Federico Innocenti Hiroyuki Takeda Yohei Kubota Ayako Doi Yoshiki Horie Kumiko Umemoto Naoki Izawa Jingyuan Wang Francesca Battaglin Priya Jayachandran Sandra Algaze Shivani Soni Wu Zhang Richard M Goldberg Michael J Hall Aaron James Scott Jimmy J Hwang Emil Lou Benjamin A Weinberg John Marshall Sanjay Goel Joanne Xiu W Michael Korn Alan P Venook Yu Sunakawa Heinz-Josef Lenz
- Networks:
- CA011, CA136, CAPITAL, LAPS-MN026, LAPS-NC007, LAPS-OH007, MN022, MONTEFIORE, MUSC, NC002, SCOR
- Study
- Alliance-A152108
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-80405
- Phases:
- N/A, 3
- Keywords: